PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.75 +0.08 (+4.79%)
At close: Oct 1, 2026 · 4:00 PM EDT

PMV Pharmaceuticals (PMVP) Cash from Financing Activities (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) recorded Cash from Financing Activities of $143,000 in Q2 2026, up 38.8% from $103,000 a year earlier.

Analysis

PMV Pharmaceuticals (PMVP) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a TTM basis, PMV Pharmaceuticals' Cash from Financing Activities came in at $535,000 as of Jun 30, 2026, up 87.7% year-over-year; for FY2025, it was $505,000, up 61.3% from FY2024.

  • Annual Cash from Financing Activities has a five-year compound annual growth rate of -72.0% (FY2020 to FY2025).
  • Across earlier years, Cash from Financing Activities came in at $313,000 in FY2024 (-99.1%), $35.58 million in FY2023, $958,000 in FY2022 (-52.6%) and $2.02 million in FY2021 (-99.3%).
  • Quarterly Cash from Financing Activities has ranged from $6,000 in Q3 2022 to $33.15 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Cash from Financing Activities rose in two of the last four quarters, with growth averaging 24.9%.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 672.1% in Q2 2023, against a decline of 99.9% in Q3 2021 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 PMV Pharmaceuticals 89.28 Mn -325.89 Mn - 143,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143,000.00
Dec 31, 2025 392,000.00
Jun 30, 2025 103,000.00
Mar 31, 2025 10,000.00
Dec 31, 2024 172,000.00
Jun 30, 2024 141,000.00
Dec 31, 2023 288,000.00
Sep 30, 2023 33.15 Mn
Jun 30, 2023 2.13 Mn
Mar 31, 2023 12,000.00
Dec 31, 2022 548,000.00
Sep 30, 2022 6,000.00
Jun 30, 2022 276,000.00
Mar 31, 2022 128,000.00
Dec 31, 2021 295,000.00
Sep 30, 2021 309,000.00
Jun 30, 2021 1.26 Mn
Mar 31, 2021 162,000.00
Dec 31, 2020 -1.36 Mn
Sep 30, 2020 294.46 Mn
API Access

PMV Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PMVP&period=max&api_key=YOUR_API_KEY